Care/of Supplements: Which Patient Profiles Should Avoid This Brand

What Is Care/of and How Does It Work

Care/of is a New York-based subscription supplement company that uses an online lifestyle quiz to generate a personalized daily vitamin packet. Bayer AG acquired the brand in 2020, which added corporate infrastructure but did not change the regulatory category of the products: all remain dietary supplements governed by the Dietary Supplement Health and Education Act (DSHEA) of 1994, not pharmaceutical-grade drugs [1].

The Quiz-to-Pack Pipeline

The intake quiz asks roughly 25 questions covering diet, sleep, stress, and health goals. An algorithm maps answers to a curated subset of the brand's catalog, then ships monthly pouches. The word "personalized" is used heavily in marketing, but the U.S. Food and Drug Administration has never reviewed, validated, or approved the algorithm or any of its outputs [2]. No peer-reviewed publication has tested whether the quiz produces clinically superior outcomes compared to standard supplementation or no supplementation.

What DSHEA Actually Means for Consumers

Under DSHEA, supplement manufacturers bear responsibility for safety before marketing a product, but they are not required to submit safety data to the FDA before sale [1]. The FDA can act after a product is already on the market if adverse events are reported. This structure means that individual ingredients in a Care/of pack may have published safety signals in specific populations long before any regulatory action occurs.

Patients Who Should Avoid or Use Extreme Caution With Care/of

Several specific patient profiles carry meaningful clinical risk when using Care/of packs without physician oversight. These are not theoretical concerns: they are grounded in pharmacokinetic interaction data, case series, and guideline warnings.

Patients on Anticoagulants (Warfarin, Apixaban, Rivaroxaban)

Care/of commonly recommends omega-3 fatty acids and Vitamin K2. Both interact with anticoagulation therapy. High-dose omega-3 supplementation (3 to 4 g/day of EPA plus DHA) has been associated with increased bleeding time, and an umbrella review of 14 meta-analyses found that omega-3 supplementation at doses above 2 g/day produced statistically significant effects on platelet aggregation [3]. Vitamin K2 (menaquinone) directly antagonizes warfarin's mechanism of action by restoring gamma-carboxylation of clotting factors II, VII, IX, and X [4].

For patients on warfarin specifically, even small, inconsistent doses of Vitamin K2 can destabilize INR control. The American Heart Association's position on dietary supplement use in patients receiving antithrombotic therapy cautions that any supplement affecting clotting pathways should be disclosed to a prescribing clinician [5].

Practical implication: if you take any oral anticoagulant, a subscription pack that ships monthly without ongoing INR monitoring is not a safe model for Vitamin K or high-dose omega-3 delivery.

Patients With Thyroid Disorders on Levothyroxine

Care/of offers iodine, selenium, and ashwagandha, all of which interact with thyroid physiology. Iodine excess in Hashimoto's thyroiditis can trigger the Wolff-Chaikoff effect, transiently suppressing thyroid hormone synthesis, and chronic excess iodine intake has been linked to autoimmune thyroid flares in susceptible individuals [6]. A 2022 systematic review in Thyroid confirmed that iodine supplementation in iodine-sufficient populations with pre-existing autoimmune thyroid disease carries a net risk rather than benefit [6].

Ashwagandha (Withania somnifera) presents a separate concern. A 2019 randomized controlled trial (N=50) published in the Journal of Alternative and Complementary Medicine found that 600 mg/day of ashwagandha root extract increased serum T3 by 41.5% and T4 by 19.6% compared to placebo over 8 weeks [7]. For a patient whose levothyroxine dose was calibrated to a baseline thyroid state, that degree of shift could produce symptoms of hyperthyroidism or require dose recalibration.

Patients Taking Immunosuppressants or Chemotherapy Agents

Elderberry and high-dose Vitamin C are both listed in Care/of's catalog and are frequently recommended by the quiz for users who cite immune health as a goal. Elderberry (Sambucus nigra) stimulates cytokine production, specifically TNF-alpha and IL-1beta [8]. For a transplant patient on tacrolimus or a rheumatoid arthritis patient on methotrexate, any agent that activates the immune cascade could partially offset the intended immunosuppression.

High-dose Vitamin C (above 1,000 mg/day) has been shown in vitro and in some clinical settings to interfere with bortezomib, a proteasome inhibitor used in multiple myeloma [9]. The mechanism involves Vitamin C's antioxidant activity blunting bortezomib-induced oxidative stress, which is part of its therapeutic mechanism.

Pregnant and Breastfeeding Individuals

Care/of offers a prenatal product, but the quiz can also recommend individual supplements outside the prenatal line to users who are pregnant. Several of these carry OB-specific warnings. Ashwagandha has uterotonic properties documented in animal models, and standard obstetric guidance from the American College of Obstetricians and Gynecologists recommends avoiding herbal supplements without documented safety in pregnancy [10].

High-dose Vitamin A (retinol form, not beta-carotene) above 10,000 IU/day is teratogenic. While Care/of does not advertise doses in that range, the cumulative effect of retinol from multiple supplements in a single pack is a concern worth calculating with a clinician.

Patients With Iron Overload Conditions (Hemochromatosis)

Iron supplementation is appropriate for confirmed deficiency but contraindicated in hereditary hemochromatosis, a condition affecting approximately 1 in 200 individuals of Northern European ancestry [11]. The Care/of quiz asks about diet but does not screen for HFE gene variants or serum ferritin. A user who reports fatigue (a common hemochromatosis symptom) may be directed toward iron-containing packs, which would worsen iron accumulation rather than address the underlying cause.

Is Care/of Legit: Regulatory and Business Standing

"Legit" covers two distinct questions: is the company operating within the law, and does the product actually do what it claims?

Regulatory and Legal Standing

Care/of operates legally under DSHEA. The company has not received FDA warning letters as of this writing (the FDA's public warning letter database at accessdata.fda.gov can be searched to verify current status) [2]. The Better Business Bureau has accredited Care/of, though consumer complaint threads on the BBB site document recurring issues with subscription cancellation difficulty and unexpected charges, a pattern that has drawn scrutiny from several state attorneys general examining subscription commerce practices broadly [12].

LegitScript, the pharmacy and supplement verification service, classifies Care/of as a legitimate dietary supplement retailer operating without the deceptive practices it flags in fraudulent supplement operations. That classification reflects business practices, not clinical efficacy.

Third-Party Testing Gaps

Some Care/of products carry NSF International or USP certifications, which verify that the labeled dose is present and that heavy metal contamination is below threshold. Not every product in the catalog holds such certification. The FDA's dietary supplement guidance recommends consumers prioritize third-party-tested products specifically because the agency lacks pre-market review authority [1]. Before starting any Care/of pack, it is worth confirming which specific products in your personalized lineup carry independent verification.

The framework below can guide that verification conversation with a clinician or pharmacist.

Care/of Ingredient Safety Check: A 4-Step Clinical Framework

1. List every ingredient in your recommended pack with its dose.
2. Cross-reference each ingredient against your current prescription and OTC medication list using a pharmacist-validated interaction checker (e.g., the NIH National Library of Medicine's DailyMed database).
3. Confirm third-party certification status for each product at NSF's public certification database (nsf.org/consumer-resources).
4. For any ingredient that modulates hormones, immunity, or coagulation, obtain explicit clearance from the prescribing clinician for that pathway before starting.

Common Care/of Complaints: What the Data Shows

Consumer complaint patterns reveal practical friction points that clinical literature does not address.

Subscription Cancellation and Billing Issues

The BBB complaint portal for Care/of lists cancellation difficulty as the most common consumer complaint category [12]. Consumers report charges continuing after cancellation requests, a recurring issue across many subscription supplement companies. The Federal Trade Commission has published guidance specifically addressing negative-option subscription practices, and Care/of's model has been cited in broader FTC consumer education materials about auto-renewal pitfalls [13].

The clinical relevance here is indirect but real: patients who feel financially trapped in a subscription may continue taking supplements they intended to stop, prolonging any adverse effects from an incompatible ingredient.

Ingredient Dose Accuracy

No large-scale independent assay of Care/of's full product line has been published. ConsumerLab.com, a subscription-based independent testing organization, has reviewed individual Care/of products and found label-accurate doses in tested samples. That data is behind ConsumerLab's paywall and covers a small fraction of the catalog.

The FDA receives adverse event reports for dietary supplements through the MedWatch system. Searching MedWatch for Care/of by name returns a small number of reports, consistent with a mid-size supplement brand and not indicative of systematic safety failure [2]. Supplement adverse events are significantly under-reported: a 2015 study in the New England Journal of Medicine (N=63 emergency departments, estimated 23,005 annual supplement-related ER visits) found that single-ingredient micronutrient supplements and herbal products accounted for the majority of cases, with young adults and older patients disproportionately affected [14].

Customer Service and Product Customization Limitations

Several complaints note that the quiz recommendations do not update dynamically when a user reports a new medication or health condition. A user who is later prescribed warfarin, for example, would need to proactively cancel or modify their subscription. The system does not prompt reassessment when clinical circumstances change. This is a structural limitation of all quiz-based supplement subscription models, not a unique Care/of failing.

What the Clinical Literature Actually Says About Quiz-Based Personalized Supplementation

The premise underlying Care/of and similar brands is that a behavioral quiz can identify nutritional gaps and match them to supplements with sufficient precision to produce clinical benefit. That premise has limited support in the published literature.

Nutrient Deficiency Requires Biomarker Confirmation

The USPSTF's 2022 updated recommendation statement on vitamin and mineral supplementation in community-dwelling adults without known nutrient deficiencies found insufficient evidence that routine supplementation prevents cardiovascular disease or cancer in this population [15]. The recommendation explicitly applies to healthy adults without documented deficiency, which is precisely the demographic most likely to use Care/of based on quiz results rather than lab confirmation.

The USPSTF statement notes: "The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamins for the prevention of cardiovascular disease or cancer" [15]. That conclusion does not mean supplements lack value in deficiency states; it means quiz-derived recommendations without biomarker confirmation operate outside the evidence base.

Validated Conditions Where Supplementation Helps

Specific deficiency-confirmed states have solid evidence behind supplementation:

• Vitamin D3 supplementation in adults with serum 25(OH)D below 20 ng/mL reduces fracture risk. The VITAL trial (N=25,871) found that Vitamin D3 at 2,000 IU/day did not reduce cancer incidence or major cardiovascular events in the overall population, but secondary analyses showed reduced cancer mortality in those who took it for at least 2 years [16].

• Folic acid at 400 to 800 mcg/day before conception and during the first trimester reduces neural tube defect risk by approximately 70%, a finding replicated across multiple RCTs and adopted in ACOG guidelines [10].

• Iron supplementation in confirmed iron-deficiency anemia (serum ferritin below 12 mcg/L) raises hemoglobin effectively and is standard of care [11].

The pattern is consistent: supplementation in documented deficiency or confirmed high-risk states produces benefit. Quiz-inferred supplementation in otherwise healthy adults produces uncertain outcomes at best and specific harms in the drug-interaction and contraindicated-condition profiles described above.

Care/of vs. Clinician-Supervised Supplementation: Key Differences

A subscription model optimizes for convenience and consumer retention. A clinician-supervised supplementation plan optimizes for safety and outcome. The differences are operational, not just philosophical.

Baseline Lab Work

A clinician-supervised approach typically includes a comprehensive metabolic panel, CBC, lipid panel, and targeted micronutrient levels (25-OH Vitamin D, ferritin, B12, folate, zinc when indicated). Care/of's quiz collects none of this. A user who self-reports "low energy" may receive iron, B12, Vitamin D, and ashwagandha without knowing whether their ferritin is 8 or 280 ng/mL.

Ongoing Monitoring

Patients on levothyroxine, warfarin, or immunosuppressants require interval lab monitoring. A Care/of subscription ships regardless of lab trends. No notification system links pack contents to lab value changes.

Drug Interaction Screening

Clinical pharmacy staff at a supervised practice can cross-reference every new supplement against a patient's medication list using tools like Lexicomp or Micromedex. The Care/of quiz has no equivalent cross-check and no pharmacist review in the fulfillment pipeline.

Practical Guidance: Should You Use Care/of

Care/of may be appropriate for healthy adults with no chronic conditions, no prescription medications, and no known nutrient deficiencies who are seeking general wellness support and have confirmed that the recommended ingredients carry third-party certification. The product is not appropriate as a substitute for clinician-guided supplementation in any patient with:

• Active anticoagulation therapy
• Thyroid disease on medication
• Autoimmune disease on immunosuppressants
• Active or recent cancer treatment
• Pregnancy or planned pregnancy
• Hereditary hemochromatosis or other iron-overload conditions
• Chronic kidney disease (Vitamin C above 1,000 mg/day increases oxalate load and stone risk in CKD patients) [17]

For any individual in those categories, the starting point is a conversation with a prescribing clinician and a pharmacist before adding any supplement, regardless of the brand. The monthly convenience of an auto-ship pack does not outweigh the risk of an unmonitored drug-supplement interaction.